Table 4.
Treatments and complications during hospital stay.
| Total cohort (N=111) | Asymptomatic (n=43) | Symptomatic (n=68) | P value | ||
| Treatment, n (%) | |||||
|
|
Hydroxychloroquine | 17 (15.3) | 5 (11.6) | 12 (17.6) | .28 |
|
|
Azithromycin | 4 (3.6) | 2 (4.7) | 2 (2.9) | .50 |
|
|
Antibiotics | 6 (5.4) | 3 (7) | 3 (4.4) | .16 |
|
|
Lopinavir-ritonavir | 1 (0.9) | 0 (0) | 1 (1.5) | .61 |
|
|
Steroids | 1 (0.9) | 0 (0) | 1 (1.5) | .61 |
| Complications | |||||
|
|
Pneumonia, n (%) | 3 (2.7) | 0 (0) | 3 (100) | N/A |
|
|
Duration of hospitalization days, median (range) | 8 (0-30) | 7 (1-25) | 9 (0-30) | .19 |
| Outcome, n (%) | |||||
|
|
Discharge | 111 (100) | 43 | 68 | N/Aa |
|
|
Deaths | 0 (0) | 0 (0) | 0 (0) | N/A |
aN/A: not applicable